USPTO Office Action, and Myriad Genetics' Subsequent Response
Repository Usage Stats
DescriptionThe USPTO requested that Myriad restrict its application to one invention, and suggested ways to group claims in distinct inventions; Myriad responded with alternate combinations of claims into fewer new distinct inventions.
SubjectGenetics, Myriad Genetics, BRCA, Breast Cancer, Gene Patents, Law, Health Policy, Medicine, Women’s Health
CitationUnited States Patent and Trade Office; & Myriad Genetics, Inc. (1997). USPTO Office Action, and Myriad Genetics' Subsequent Response. Retrieved from https://hdl.handle.net/10161/7674.
More InfoShow full item record